Literature DB >> 8788544

Interleukin-1 signal transduction.

L A O'Neill1.   

Abstract

Interleukin 1 (IL1) is a potent pro-inflammatory cytokine which has been implicated in the pathogenesis of chronic inflammatory disease. Despite much effect, the signal transduction pathway activated by IL1 has remained obscure. Recently, much attention has focussed on IL1 receptors and early events triggered by IL1 in cells, including activation of transcription factors and serine/threonine protein kinases. Two main types of IL1 receptors have been described, IL1RI and IL1RII. They appear to belong to a family of proteins which include most notably a Drosophila protein, Toll. Following receptor binding IL1 has been shown to increase protein phosphorylation in cells, and much effort has been made to identify the protein kinases responsible. Novel enzymes have been discovered, including a family of MAP kinase--like enzymes which are also activated by a range of stresses such as hypertonic stress and heat shock. Attention has also been focussed in the activation of the transcription factor NF kappa B, which is rapidly activated by IL1. This review will describe our current understanding of how IL1 activated cells and will particularly describe more recent work on IL1 receptors and early post-receptors events.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788544     DOI: 10.1007/bf02592694

Source DB:  PubMed          Journal:  Int J Clin Lab Res        ISSN: 0940-5437


  9 in total

Review 1.  Stress-induced corneal epithelial apoptosis mediated by K+ channel activation.

Authors:  Luo Lu
Journal:  Prog Retin Eye Res       Date:  2006-09-07       Impact factor: 21.198

2.  Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells.

Authors:  Ling Wang; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

Review 3.  A primer on cytokines: sources, receptors, effects, and inducers.

Authors:  J H Curfs; J F Meis; J A Hoogkamp-Korstanje
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

4.  Mechanism of TH2/TH17-predominant and neutrophilic TH2/TH17-low subtypes of asthma.

Authors:  Weimin Liu; Sucai Liu; Mukesh Verma; Iram Zafar; James T Good; Donald Rollins; Stephen Groshong; Magdalena M Gorska; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2016-10-01       Impact factor: 10.793

5.  Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk.

Authors:  Shekher Mohan; Randall L Davis; Udaya DeSilva; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2010-07-07       Impact factor: 3.478

6.  Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood.

Authors:  S Milano; F Arcoleo; P D'Agostino; E Cillari
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.

Authors:  Alyssa Carey; David K Edwards; Christopher A Eide; Laura Newell; Elie Traer; Bruno C Medeiros; Daniel A Pollyea; Michael W Deininger; Robert H Collins; Jeffrey W Tyner; Brian J Druker; Grover C Bagby; Shannon K McWeeney; Anupriya Agarwal
Journal:  Cell Rep       Date:  2017-03-28       Impact factor: 9.423

Review 8.  Pharmacology of intra-articular triamcinolone.

Authors:  Justin Scherer; K D Rainsford; Colin A Kean; Walter F Kean
Journal:  Inflammopharmacology       Date:  2014-05-14       Impact factor: 4.473

9.  Evolutionary divergence and functions of the human interleukin (IL) gene family.

Authors:  Chad Brocker; David Thompson; Akiko Matsumoto; Daniel W Nebert; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2010-10       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.